On December 16, 2010
Elan’s Epilepsy Drug Is Toast, But a Prescribing Doc Is Up $11 M
Elan’s $203.5 million settlement of a case in which it illegally promoted an epilepsy drug for weight loss reveals how little off-label activity needs to occur before liabilities kick in.
No tags for this post.
0 Comments